home / stock / bioyf / bioyf short
Short Information | BioSyent Inc. (OTCMKTS:BIOYF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 32,027 |
Total Actual Volume | 44,146 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 14 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 1,601 |
Average Short Percentage | 72.21% |
Is there a BIOYF Short Squeeze or Breakout about to happen?
See the BIOYF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-25-2024 | $7.59 | $7.5018 | $7.59 | $7.5018 | 1,593 | 1,093 | 68.61% |
06-24-2024 | $7.72 | $7.62 | $7.73 | $7.62 | 2,165 | 1,965 | 90.76% |
06-21-2024 | $7.35 | $7.35 | $7.35 | $7.35 | 300 | 200 | 66.67% |
06-20-2024 | $6.97 | $7.19 | $7.19 | $6.97 | 606 | 515 | 84.98% |
06-18-2024 | $6.95 | $7.05 | $7.05 | $6.95 | 475 | 475 | 100% |
06-17-2024 | $7.2 | $6.93 | $7.2 | $6.93 | 370 | 370 | 100% |
06-14-2024 | $7.28 | $7 | $7.28 | $7 | 6,876 | 6,876 | 100% |
06-13-2024 | $6.85 | $6.8 | $6.85 | $6.8 | 724 | 624 | 86.19% |
06-11-2024 | $6.69 | $6.69 | $6.69 | $6.69 | 155 | 155 | 100% |
06-07-2024 | $6.69 | $6.69 | $6.69 | $6.69 | 368 | 317 | 86.14% |
06-04-2024 | $0 | $6.665 | $0 | $0 | 5 | 5 | 100% |
06-03-2024 | $6.6799 | $6.665 | $6.6799 | $6.665 | 1,340 | 550 | 41.04% |
05-31-2024 | $6.65 | $6.66 | $6.66 | $6.65 | 1,420 | 420 | 29.58% |
05-30-2024 | $6.62 | $6.6365 | $6.6365 | $6.62 | 1,741 | 421 | 24.18% |
05-29-2024 | $6.62 | $6.62 | $6.662 | $6.62 | 7,009 | 5,825 | 83.11% |
05-28-2024 | $6.6914 | $6.96 | $6.96 | $6.59 | 3,323 | 1,240 | 37.32% |
05-24-2024 | $6.66 | $6.59 | $6.7 | $6.59 | 4,368 | 4,218 | 96.57% |
05-23-2024 | $6.5701 | $6.55 | $6.5701 | $6.51 | 4,681 | 2,202 | 47.04% |
05-22-2024 | $6.62 | $6.55 | $6.62 | $6.54 | 1,815 | 215 | 11.85% |
05-21-2024 | $6.66 | $6.62 | $6.66 | $6.51 | 4,812 | 4,341 | 90.21% |
News, Short Squeeze, Breakout and More Instantly...
MISSISSAUGA, Ontario, June 12, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has entered into an agreement with a Euro...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include: Return on Equity for TTM March 31, 2024 was 21% as compared to 15% ...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 20...